Evidence map›Paper›PMID 38675764›Full record

ArticleVaccines2024

Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A

Tania Rivera-Hernandez, Diane G Carnathan, Johanna Richter, Patrick Marchant, Amanda J Cork, Gayathiri Elangovan, Anna Henningham, Jason N Cole, Biswa Choudhury, Peter M Moyle and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Tania Rivera-HernandezConsejo Nacional de Humanidades Ciencia y Tecnología, Unidad de Investigación Médica en Inmunoquímica, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
Diane G CarnathanEmory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Johanna RichterInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.ORCID 0000-0002-2043-0003
Patrick MarchantVaxcyte Inc., San Carlos, CA 94070, USA.
Amanda J CorkInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.ORCID 0000-0003-2207-6877
Gayathiri ElangovanInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
Anna HenninghamDivision of Ob/Gyn & Reproductive Sciences, Vc-Health Sciences-Schools, University of California San Diego, La Jolla, CA 92093, USA.
Jason N ColeDivision of Ob/Gyn & Reproductive Sciences, Vc-Health Sciences-Schools, University of California San Diego, La Jolla, CA 92093, USA.
Biswa ChoudhuryDivision of Ob/Gyn & Reproductive Sciences, Vc-Health Sciences-Schools, University of California San Diego, La Jolla, CA 92093, USA.
Peter M MoyleSchool of Pharmacy, The University of Queensland, St. Lucia, QLD 4072, Australia.ORCID 0000-0002-9247-681X
Istvan TothSchool of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD 4072, Australia.
Michael R BatzloffInstitute for Glycomics, Griffith University, Gold Coast, QLD 4222, Australia.
Michael F GoodInstitute for Glycomics, Griffith University, Gold Coast, QLD 4222, Australia.
Paresh AgarwalVaxcyte Inc., San Carlos, CA 94070, USA.
Neeraj KapoorVaxcyte Inc., San Carlos, CA 94070, USA.
Victor NizetDivision of Ob/Gyn & Reproductive Sciences, Vc-Health Sciences-Schools, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0003-3847-0422
Guido SilvestriEmory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Mark J WalkerInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
The University of Queensland · AUUniversity of California San Diego · USEmory University · USGriffith University · AUMexican Social Security Institute · MX

Funding

Identifying the Most Effective Adjuvant(s) for Leading Group A Streptococcal Vaccine Antigens in Preclinical Mouse and Nonhuman Primate ModelsR01AI173689 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Victor Nizet, Mark Joseph Walker · 2023 to 2026
$2.8M
NIAID NIH HHS R01 AI173689NIH HHS AI173689-01
6 · The paper itself

Abstract

Vaccine development against group A

Indexed as

group A carbohydrategroup A StreptococcusJ8 peptideStreptococcus pyogenesvaccine

Identifiers

PMID38675764
PMCPMC11054769
OpenAlexW4393934807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.